Hereditary predisposition to breast cancer

被引:33
|
作者
Stratton, MR
Wooster, R
机构
[1] Haddow Laboratories, Institute of Cancer Research, Sutton, Surrey, SM2 5NG
关键词
D O I
10.1016/S0959-437X(96)90017-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The breast cancer susceptibility gene on chromosome 17q, BRCA1, has now been isolated. Mutations in this gene have been detected in many families with a predisposition to breast cancer. Most of these mutations result in truncation and presumed inactivation of the BRCA1 protein. A large number of distinct mutations have been reported, although some families have identical mutations, probably due to a founder effect. Certain evidence suggests that mutations positioned towards the 5' end of the gene carry a higher risk of ovarian cancer than those at the 3' end. BRCA1 is infrequently somatically mutated in sporadic breast or ovarian cancer. The BRCA2 gene has been localized to chromosome 13q12-q13. BRCA2 carries a risk of breast cancer similar to that of BRCA1, but is associated with a lower risk of ovarian cancer and a higher risk of male breast cancer. Additional breast cancer susceptibility genes probably exist, but may be difficult to locate by conventional methods.
引用
收藏
页码:93 / 97
页数:5
相关论文
共 50 条
  • [31] MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis
    Filippo Santoro
    Franca Podo
    Francesco Sardanelli
    Breast Cancer Research and Treatment, 2014, 147 : 685 - 687
  • [32] MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis
    Tharmaratnam, Kukatharmini
    Hagen, Anne Irene
    Moller, Pal
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 148 (03) : 687 - 688
  • [33] Hereditary breast and ovarian cancer predisposition management for asymptomatic patient carrier of a BRCA mutation
    Bonfanti, Arianna
    Cordier, Christophe
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 560 - 560
  • [34] MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis
    Kukatharmini Tharmaratnam
    Anne Irene Hagen
    Pål Møller
    Breast Cancer Research and Treatment, 2014, 148 : 687 - 688
  • [35] MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis
    Santoro, Filippo
    Podo, Franca
    Sardanelli, Francesco
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (03) : 685 - 687
  • [36] Diagnosing hereditary cancer predisposition in men with prostate cancer
    Pritzlaff, Mary
    Tian, Yuan
    Reineke, Patrick
    Stuenkel, A. J.
    Allen, Kyle
    Gutierrez, Stephanie
    Jackson, Michelle
    Dolinsky, Jill S.
    LaDuca, Holly
    Xu, Jianfeng
    Black, Mary Helen
    Helfand, Brian T.
    GENETICS IN MEDICINE, 2020, 22 (09) : 1517 - 1523
  • [37] The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition
    Moretta, Jessica
    Berthet, Pascaline
    Bonadona, Valerie
    Caron, Olivier
    Cohen-Haguenauer, Odile
    Colas, Chrystelle
    Corsini, Carole
    Cusin, Veronica
    De Pauw, Antoine
    Delnatte, Capucine
    Dussart, Sophie
    Jamain, Christophe
    Longy, Michel
    Luporsi, Elisabeth
    Maugard, Christine
    Tan Dat Nguyen
    Pujol, Pascal
    Vaur, Dominique
    Andrieu, Nadine
    Lasset, Christine
    Nogues, Catherine
    BULLETIN DU CANCER, 2018, 105 (10) : 907 - 917
  • [38] Breast asymmetry and predisposition to breast cancer
    Diane Scutt
    Gillian A Lancaster
    John T Manning
    Breast Cancer Research, 8
  • [39] Breast asymmetry and predisposition to breast cancer
    Scutt, D
    Lancaster, GA
    T Manning, J
    BREAST CANCER RESEARCH, 2006, 8 (02):
  • [40] Germline Testing for the Evaluation of Hereditary Cancer Predisposition
    Ceyhan-Birsoy, Ozge
    CLINICS IN LABORATORY MEDICINE, 2022, 42 (03) : 497 - 506